期刊文献+

马尼地平脂质体的制备及其质量研究 被引量:1

Study on preparation of manidipine liposomes and its quality
暂未订购
导出
摘要 目的优选马尼地平脂质体的处方和制备工艺,并对其进行质量研究。方法采用乙醇注入法制备马尼地平脂质体,并对其形态学、粒径、包封率、初步稳定性等性质进行了研究。结果在透射电子显微镜下观察,制备的马尼地平脂质体为均匀的球状或近球状,平均粒径为233.9 nm,包封率为89.6%,脂质体4℃放置稳定。结论选择乙醇注入法优化工艺制备马尼地平脂质体稳定可行,为进一步开发马尼地平新制剂提供了实验依据。 Objective To optimize the prescription and preparation technology of manidipine(MNDP) liposomes, and to study its quality. Methods MNDP liposomes were prepared by the method of ethanol injection. And their morphology, particle diameter, envelopment rate and the primary stability were studied. Results Observed under the transmission electron microscope, the MNDP liposomes were in the shape of even globosity or near - sphere. Their average particle diameter was 233.9 nm, and the envelopment rate was 89.6%. The liposomes were stable when stored at 4 ℃. Conclusion It is stable and feasible to prepare the MNDP liposomes by the optimized method of ethanol injection, which provides experimental evidences for the development of new MNDP preparations.
出处 《西南国防医药》 CAS 2011年第11期1176-1178,共3页 Medical Journal of National Defending Forces in Southwest China
关键词 马尼地平 脂质体 制备 质量评价 manidipine liposomes preparation quality evaluation
  • 相关文献

参考文献2

二级参考文献20

  • 1[1]DHEIN S, SALAMEH A, BERKELS R, et al. Dual mode of action of dihydropyridine calcium antagonists: a role for nitric oxide[J]. Drugs, 1999, 58(3):397-404.
  • 2[2]Anon. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure[J]. Arch Intern Med, 1997, 157(21):2413-2446.
  • 3[3]LUSCHER TF, COSENTINO F. The classification of calcium antagonists and their selection in the treatment of hypertension: a reappraisal[J]. Drugs, 1998, 55(4):509-517.
  • 4[4]OKABE K, TERADA K, KITAMURA K, et al. Selective and long-lasting inhibitory action of the dihydropyridine derivative, CV-4093, on calcium currents in smooth muscle cells of the rabbit pulmonary artery[J]. J Pharmacol Exp Ther, 1987, 243(2):703-710.
  • 5[5]CHEER SM, MCCLELLAN K. Manidipine: a review of its use in hypertension[J]. Drugs, 2001, 61(12):1777-1799.
  • 6[6]PFAFFENDORF M, MATHY MJ, van ZWIETEN PA. Effects of manidipine and other calcium antagonists on rat renal arcuate arteries[J]. Am Heart J, 1993, 125(2 Pt 2): 571-577.
  • 7[7]FOGARI R, ZOPPI A, MUGELLINI A, et al. Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives[J]. Cardiovasc Drugs Ther, 1999, 13(3):243-248.
  • 8[8]MANCIA G, OMBONI S, AGABITI-ROSEI E, et al. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients[J]. J Cardiovas Pharmacol, 2000, 35(6):926-931.
  • 9[9]HASE MI, HASE O, IGAWA S, et al. Reduction of left ventricular mass by manidipine hydrochloride[J]. Am J Hypertens, 1998, 11(4 Pt 2):81A.
  • 10[10]TAKABATAKE T, USHIOGI Y, ISE T, et al. Effect of calcium antagonist, manidipine hydrochloride, on renal hemodynamics and tubuloglomerular feedback in spontaneously hypertensive rats[J]. Am Heart J, 1993, 125(2 Pt 2):578-581.

共引文献27

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部